CL
Clariant AG
CLZNY · OTC
$12.59 +0.32% (+$0.04)
1M -4.84%
Market Cap CHF 3.40B
P/E Ratio -
Div. Yield 3.70%
ROE 3.46%
Bulios Fair Price
$7.57
39.9% downside
Current Price
$12.59
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CLZNY is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
76 /100
Cheap P/S 0.91x
P/B 1.68x
P/FCF 15.24x
Growth
7 /100
Declining FCF growth 8.32%
Book val. growth 4.70%
Rev. growth 10.40%
Profitability
57 /100
Moderate Net margin 1.92%
Op. margin 10.17%
FCF margin 5.98%
Quality
10 /100
Poor ROE 3.46%
ROA 1.22%
Asset turnover 0.64x
Debt
56 /100
Moderate Current ratio 1.64x
Int. coverage 1.19x
Net debt/EBITDA 2.61x
Stability
32 /100
Unstable Rev. volatility 5.34%
EPS volatility 168.06%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CLZNY
Online
Sector
Basic Materials
Industry
Chemicals - Specialty
CEO
Conrad Keijzer
Employees
10,281
Headquarters
Muttenz
Upcoming events
23 FEB
Earnings
Upcoming earnings report